-transparent.png){kind=logo}
A patient on disopyramide developed disopyramide toxicity when treated concurrently with azithromycin. Evidence of toxicity included an elevated serum disopyramide level and ventricular tachycardia requiring cardioversion. The azalide antibiotic presumably inhibited dealkylation of disopyramide to its major metabolite, mono-N-dealkyldisopyramide. Physicians should avoid using azithromycin in patients on disopyramide. If this drug combination is unavoidable, disopyramide levels must be closely monitored.
Related Publications
E V Granowitz, and
K J Tabor, and
J B Kirchhoffer
April 1989,
The American journal of medicine,
E V Granowitz, and
K J Tabor, and
J B Kirchhoffer
April 2004,
Annals of internal medicine,
E V Granowitz, and
K J Tabor, and
J B Kirchhoffer
October 2009,
Progress in neuro-psychopharmacology & biological psychiatry,
E V Granowitz, and
K J Tabor, and
J B Kirchhoffer
November 1979,
British medical journal,
E V Granowitz, and
K J Tabor, and
J B Kirchhoffer
November 1983,
Ugeskrift for laeger,
E V Granowitz, and
K J Tabor, and
J B Kirchhoffer
October 1986,
The British journal of clinical practice,
E V Granowitz, and
K J Tabor, and
J B Kirchhoffer
January 1996,
Nephron,
E V Granowitz, and
K J Tabor, and
J B Kirchhoffer
February 1997,
Lancet (London, England),
E V Granowitz, and
K J Tabor, and
J B Kirchhoffer
August 1983,
Clinical pharmacology and therapeutics,
E V Granowitz, and
K J Tabor, and
J B Kirchhoffer
November 1978,
Irish medical journal,
